Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel

Cancer Genetics and Cytogenetics

Volumn 121, Issue 1, 2000, Pages 26-32

  Patael Karasik, Yael ^a   Daniely, Michal ^a   Gotlieb, Walter H ^a   Ben Baruch, Gilad ^a   Schiby, Jinette ^a   Barakai, Gad ^a   Goldman, Boleslaw ^a   Aviram, Ayala ^a   Friedman, Eitan ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 19; CHROMOSOME 9; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENETIC PREDISPOSITION; HUMAN; HUMAN TISSUE; ISRAEL; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BRCA2 PROTEIN; CHROMOSOME ABERRATIONS; DNA; DNA, NEOPLASM; FEMALE; GENE DOSAGE; GENES, BRCA1; HETEROZYGOTE; HUMANS; ISRAEL; JEWS; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; NUCLEIC ACID HYBRIDIZATION; OVARIAN NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0033848571     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(00)00224-7     Document Type: Article

References (37)

1. Phyllis A., Tony T., Sherry B. Cancer statistics. CA - Cancer J Clin. 45:1995;8-30.
2. Israel Cancer Registry (1994): Cancer in Israel: facts and figures, 1986-1989, Jerusalem.
3. Modan B., Gak E., Hirsh G., Bar-Sade Brucim R., Theodor L., Lubin F., Ben-Baruch G., Beller U., Fishman A., Dgani R., Menczer J., Papa M.Z., Friedman E. High frequency of the 185delAG mutation in ovarian cancer in Israel. JAMA. 276:1996;1823-1825.
4. Abeliovich D., Kaduri L., Lerer I., Weinberg N., Amir G., Sagi M., Zlotogora J., Heching N., Peretz T. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer patients among Ashkenazi women. Am J Hum Genet. 60:1997;505-514.
5. Pejovic T. Genetic changes in ovarian cancer. Ann Med. 27:1995;73-78.
6. Osborne R.J., Leech V. Polymerase chain reaction allelotyping of human ovarian cancer. Br J Cancer. 69:1994;429-438.
7. Berchuck A., Kamel A., Whitaker R., Kerns B., Olt G., Kinney R., Soper J.T., Dodge R., Clarke-Pearson D.L., Marks P. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res. 50:1990;4087-4091.
8. Yang-Feng T.L., Han H., Chen K.C., Li S.B., Claus E.B., Carcangiu M.L., Chambers S.K., Chambers J.T., Schwartz P.E. Allelic loss in ovarian cancer. Int J Cancer. 54:1993;546-551.
9. Berchuck A., Heron K.A., Carney M.E., Lancaster J.M., Fraser E.G., Vinson V.L., Deffenbaugh A.M., Miron A., Marks J.R., Futreal P.A., Frank T.S. Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Clin Cancer Res. 4:1998;2433-2437.
10. Lancaster J.M., Wooster R., Mangion J., Phelan C.M., Cochran C., Gumbs C., Seal S., Barfoot R., Collins N., Bignell G., Patel S., Hamoudi R., Larsson C., Wiseman R.W., Berchuck A., Iglehart J.D., Marks J.R., Ashworth A., Stratton M.R., Futreal P.A. BRCA2 mutations in primary breast and ovarian cancers. Nat Genet. 13:1996;238-240.
11. Ramus S.J., Bobrow L.G., Pharoah P.D., Finnigan D.S., Fishman A., Altaras M., Harrington P.A., Gayther S.A., Ponder B.A., Friedman L.S. Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours. Genes Chromosom Cancer. 25:1999;91-96.
12. Deger R.B., Faruqi S.A., Noumoff J.S. Karyotypic analysis of 32 malignant epithelial ovarian tumors. Cancer Genet Cytogenet. 96:1997;166-173.
13. Tibiletti M.G., Bernasconi B., Furlan D., Riva C., Trubia M., Buraggi G., Franchi M., Bolis P., Mariani A., Frigerio L., Capella C., Taramelli R. Early involvement of 6q in surface epithelial ovarian tumors. Cancer Res. 56:1996;4493-4498.
14. Pejovic T. Genetic changes in ovarian cancer. Ann Med. 27:1995;73-78.
15. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Gray J.W., Waldman F., Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 258:1992;818-821.
16. Hermsen M.A.J.A., Meijer G.A., Baak J.P.A., Joenje H., Walboomers J.J.M. Comparative genomic hybridization. a new tool in cancer pathology Hum Pathol. 4:1996;342-349.
17. Kallioniemi A., Kallioniemi O.P., Piper J., Tanner M., Stokke T., Chen L., Smith H.S., Pinkel D., Gray J.W., Waldman F.M. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA. 91:1994;2156-2160.
18. du Manoir S., Speicher M.R., Joos S., Schrock E., Popp S., Dohner H., Kovacs G., Robert-Nicoud M., Lichter P., Cremer T. Detection of complete and partial chromosomal gains and losses by comparative genomic in situ hybridization. Hum Genet. 90:1993;590-610.
19. Lundsteen C., Maaher J., Christensen B., Bryndorf T., Bentz M., Lichter P., Gerdes T. Image analysis in comparative genomic hybridization. Cytometry. 19:1995;42-50.
20. Bryndorf T., Kirschoff M., Rose H., Maahr J., Gerdes T., Karhu R., Kallioniemi A., Christensen B., Lundsteen C., Philip J. Comparative genomic hybridization in clinical cytogenetics. Am J Hum Genet. 57:1995;1211-1220.
21. Arnold N., Hagele L., Walz L., Schempp W., Pfisterer J., Bauknecht T., Kiechle M. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosom Cancer. 16:1996;46-54.
22. Tapper J., Sarantaus L., Vahteristo P., Nevanlinna H., Hemmer S., Seppala M., Knuutila S., Butzow R. Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization. extensive similarity except for a difference at chromosome 2q24-q32 Cancer Res. 58:1998;2715-2719.
23. Sonoda G., Palazzo J., du Manoir S., Godwin A.K., Feder M., Yakushiji M., Testa J.R. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosom Cancer. 20:1997;320-328.
24. Iwabuchi H., Sakamoto M., Sakunaga H., Ma Y.Y., Carcangiu M.L., Pinkel D., Yang-Feng T.L., Gray J.W. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res. 55:1995;6172-6180.
25. Baker V.V., Borst M.P., Dixon D., Hatch K.D., Shingleton H.M., Miller D. c-myc amplification in ovarian cancer. Gynecol Oncol. 38:1990;340-342.
26. Corey S.J., Shapiro D.N. Localization of the human gene for Src-related protein tyrosine kinase LYN to chromosome 8q11-12. a lymphoid signaling cluster? Leukemia. 8:1991;1914-1917.
27. Dolcetti R., Pelucchi S., Maestro R., Rizzo S., Pastore A., Boiocchi M. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx. Eur Arch Otorhinolaryngol. 248:1991;279-285.
28. Simoneaux D.K., Fletcher F.A., Jurecic R., Shilling H.G., Van N.T., Patel P., Belmont J.W. The receptor tyrosine kinase-related gene (ryk) demonstrates lineage and stage-specific expression in hematopoietic cells. J Immunol. 154:1995;1157-1166.
29. Shayesteh L., Lu Y., Kuo W.L., Baldocchi R., Godfrey T., Collins C., Pinkel D., Powell B., Mills G.B., Gray J.W. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet. 21:1999;99-102.
30. Pere H., Tapper J., Seppala M., Knuutila S., Butzow R. Genomic alterations in fallopian tube carcinoma. comparison to serous uterine and ovarian carcinomas reveals similarity suggesting likeness in molecular pathogenesis Cancer Res. 58:1998;4274-4276.
31. Kupryjanczyk J., Thor A.D., Beauchamp R., Poremba C., Scully R.E., Yandell D.W. Ovarian, peritoneal, and endometrial serous carcinoma. clonal origin of multifocal disease Mod Pathol. 9:1996;166-173.
32. Schorge J.O., Muto M.G., Welch W.R., Bandera C.A., Rubin S.C., Bell D.A., Berkowitz R.S., Mok S.C. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst. 90:1998;841-845.
33. Schorge J.O., Mok S.C. Understanding the pathogenesis of primary peritoneal carcinoma. involvement of the BRCA1 and p53 genes Hum Pathol. 30:1999;115-116.
34. Tirkkonen M., Tanner M., Karhu R., Kallioniemi A., Isola J., Kallioniemi O.P. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosom Cancer. 21:1998;177-184.
35. Tirkkonen M., Kainu T., Loman N., Johannsson O.T., Olsson H., Barkardottir R.B., Kallioniemi O.P., Borg A. Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer. Genes Chromosom Cancer. 24:1999;56-61.
36. Wolf N.G., Abdul-Karim F.W., Farver C., Schrock E., du Manoir S., Schwartz S. Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosom Cancer. 25:1990;307-315.
37. Wu L.C., Wang Z.W., Tsan J.T., Spillman M.A., Phung A., Xu X.L., Yang M.C., Hwang L.Y., Bowcock A.M., Baer R. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet. 14:1996;430-440.